The anti-mRNA sentiment — coupled with the sweeping shake-up of science funding across the United States — has sparked fears ...

As the field of personalized medicine evolves, digital technologies are playing a central role in revolutionizing cancer ...

Company aims to develop a bird flu vaccine with rapid mass production and variant responsiveness. SK bioscience and KDCA join ...

The US Department of Health and Human Services announced the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine.

Bird flu is continuing to spread in animals across the U.S. Here's what you need to know about the current situation.

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

With some mRNA approaches also using AI to personalise each vaccine to the patient, there are also questions about how to regulate a product that can differ each time it is delivered. As such ...

While human-to-human transmission of avian influenza remains low ... SK bioscience is also developing mRNA vaccines as part of its pandemic preparedness strategy. The mRNA technology, which ...

In this week’s edition of InnovationRx, we look at Aetna’s withdrawal from the ACA exchanges, the potential for digital ...

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory ... candidate also in phase 2 and one for avian influenza in phase 1. GSK said that the data so ...